Replies to post #38893 on RespireRx Pharmaceuticals Inc (RSPI)

[atheroprevent]

Actually Hay, this board is now the only source of Corx info for me, meager as it is.

It is interesting that you chose to ignore the most obvious fact. Corx valuation is such that the IP and patents could be aquired by pharma for pocket change. Who has stepped forward previously or recently? Why not?

Clearly, as Enemem has stated, the development cost and risk remain too high, regardless of ampa valuation.

If being an apologist for management means reserving judgment, I am guilty. Based on your view, Hay, I think we would have had numerous board changes during Cor life, because Cor never had a winning season. Do you think board change would have changed ampa development?

[scstocks]

====never having a critical or objective comment on the mgmt of a failed company====

Don't want to start trouble, but I know you were tuned into this board when, there was a post directly from a bio conference, talking about how bio company "reps" were nearly begging to get their "cases" heard.

That discussion painted such a scene in my mind that it literally saved me, what might have amounted to, tens of thousands of dollars.

Pretty neat to have that kind of perspective, and one I have rarely, if ever, encountered on I-hub. Who knows, it might have actually paid for my subscription, ha, I mean, YIKES.

GLTU